Brilivog-GM 0.2/2 Tablet SR
Marketer
Osiante Biotech
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Brilivog-GM 0.2/2 Tablet SR
GlycemaDuo 0.2/2mg Extended-Release Tablets are anti-diabetic medications combining two agents to manage type 2 diabetes in adults. They help regulate blood glucose. GlycemaDuo 0.2/2mg ER Tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate blood glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and trembling, and know how to treat them. Maintain regular meals and carry a fast-acting glucose source. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Disclose any history of heart disease to your physician before use. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function will be necessary.
Uses of Brilivog-GM 0.2/2 Tablet SR
Managing type 2 diabetes
Major Benefits of Brilivog-GM 0.2/2 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Brilivog-GM 0.2/2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Brilivog-GM 0.2/2 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Brilivog-GM 0.2/2 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Brilivog-GM 0.2/2 Tablet SR on an empty stomach.
How Brilivog-GM 0.2/2 Tablet SR works:
Brilivog-GM 0.2/2 extended-release tablets contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Brilivog-GM 0.2/2 Tablet SR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Brilivog-GM 0.2/2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Brilivog-GM 0.2/2 Tablet SR while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Brilivog-GM 0.2/2 Tablet SR, as its use may be unsafe. Medical advice is recommended. Moreover, Brilivog-GM 0.2/2 Tablet SR is unsuitable for individuals with severely impaired kidney function.
LiverCAUTION
Exercise caution when administering Brilivog-GM 0.2/2 Tablet SR to individuals with hepatic impairment. Dosage modification of Brilivog-GM 0.2/2 Tablet SR may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, Brilivog-GM 0.2/2 Tablet SR is typically initiated at a reduced dosage; however, its use is contraindicated in cases of severe liver disease.
What if you forget to take Brilivog-GM 0.2/2 Tablet SR :
Should you forget to take your Brilivog-GM 0.2/2 Tablet SR, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Brilivog-GM 0.2/2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes medication |
3,018 People bought this recently